Stockscreener 앱 받기
27.29
4.28%
-1.22
전일 마감가:
$28.51
열려 있는:
$28.7
하루 거래량:
151.61K
Relative Volume:
0.55
시가총액:
$558.87M
수익:
-
순이익/손실:
$-69.38M
주가수익비율:
-5.2086
EPS:
-5.2394
순현금흐름:
$-51.00M
1주 성능:
+3.43%
1개월 성능:
+6.68%
6개월 성능:
+164.95%
1년 성능:
+309.76%
1일 변동 폭
$26.92
$29.14
1주일 범위
$26.09
$30.41
52주 변동 폭
$6.13
$35.80
Forte Biosciences Inc Stock (FBRX) Company Profile
명칭
Forte Biosciences Inc
전화
(310) 618-6994
주소
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
27.29 | 558.87M | 0 | -69.38M | -51.00M | -5.2394 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 개시 | Evercore ISI | Outperform |
| 2025-08-18 | 개시 | Guggenheim | Buy |
| 2025-01-21 | 개시 | TD Cowen | Buy |
| 2024-04-08 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | 업그레이드 | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | 다운그레이드 | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | 다운그레이드 | Truist | Buy → Hold |
| 2021-05-14 | 개시 | B. Riley Securities | Buy |
| 2021-03-26 | 개시 | Citigroup | Buy |
| 2020-08-28 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | 개시 | Truist | Buy |
모두보기
Forte Biosciences Inc 주식(FBRX)의 최신 뉴스
Wall Street Zen Upgrades Forte Biosciences (NASDAQ:FBRX) to "Sell" - MarketBeat
Stock Traders Purchase High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Forte Biosciences | DEF 14A: Definitive information statements - Moomoo
[ARS] Forte Biosciences, Inc. SEC Filing - Stock Titan
Forte Biosciences (NASDAQ: FBRX) 2026 proxy seeks approval of larger equity plan - Stock Titan
Is Forte Biosciences (FBRX) stock respecting technical levels | Q4 2025: Earnings Fall ShortCrowd Trend Signals - Newser
Understanding the Setup: (FBRX) and Scalable Risk - Stock Traders Daily
FBRX (Forte Biosciences Inc.) reports wider than expected Q4 2025 loss, with shares falling 3.52% following the earnings release.Financial Update - UBND thành phố Hải Phòng
FBRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Forte Biosciences Inc stock (US34960P1012): Is its immunology focus strong enough to unlock biotech - AD HOC NEWS
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - MarketBeat
The Technical Signals Behind (FBRX) That Institutions Follow - Stock Traders Daily
Forte Biosciences Announces $150 Million Public Offering of Common Stock - Global Legal Chronicle
Quarterly Recap: Will Forte Biosciences Inc outperform small cap indexes2026 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn
Weekly Recap: Is Forte Biosciences Inc being accumulated by smart money2026 Analyst Calls & Advanced Technical Signal Analysis - baoquankhu1.vn
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX) - Seeking Alpha
Forte Biosciences: Stunning Bull Run Could Continue Thanks To Near-Term Data Readouts - Seeking Alpha
BlackBerry Posts Upbeat Q4 Results, Joins STZ, MRVL And Other Big Stocks Moving Higher On Thursday - Sahm
VIX Spike: Is Forte Biosciences Inc part of any major index2026 Pullback Review & Weekly Return Optimization Alerts - baoquankhu1.vn
Bull Bear: Does Forte Biosciences Inc have pricing powerOptions Play & Community Verified Trade Signals - baoquankhu1.vn
Forte Biosciences Boosts Market Position with $150M Public Offering - timothysykes.com
Forte Biosciences (NASDAQ: FBRX) registers 5.71M shares at $26.27 - Stock Titan
TPG closes $18 billion take-private deal, publicly traded biotech to raise $150M - The Business Journals
Brookline Capital Markets Cuts Forte Biosciences FY2026 Earnings Forecast - National Today
Forte Biosciences Prices $150 Million Public Offering - TipRanks
Forte Biosciences Prices $150 Million Stock Offering at $26.27; Underwriting Led by Guggenheim - TradingView
Forte Biosciences (NASDAQ: FBRX) prices $150M common stock sale - Stock Titan
Forte Biosciences prices 5.71M shares at $26.27 in $150M capital raise - MSN
Forte Biosciences Prices $150 Million Stock Offering - marketscreener.com
Forte Biosciences prices $150M stock offering at $26.27/share By Investing.com - Investing.com India
Forte Biosciences Announces Pricing of $150 Million Public Offering - Weekly Voice
Forte Biosciences prices $150M stock offering at $26.27/share - Investing.com
Forte Biosciences announces pricing of $150 million public offering - marketscreener.com
Forte Biosciences Announces Pricing Of $150 Million Public Offering - TradingView
Forte Biosciences launches public stock offering By Investing.com - Investing.com South Africa
Forte Biosciences launches public stock offering - Investing.com
Forte Biosciences (FBRX) files prospectus supplement to sell common stock - Stock Titan
Forte Biosciences Announces Proposed Public Offering - marketscreener.com
Drug developer Forte launches stock sale to fund clinical research - Stock Titan
Forte Biosciences Inc stock: What investors need to know in biotech volatility - AD HOC NEWS
Buybacks Report: Will Forte Biosciences Inc announce a stock splitShare Buyback & Daily Entry Point Alerts - baoquankhu1.vn
Is Forte Biosciences (FBRX) Stock Near Resistance | Price at $25.77, Up 0.74%Professional Trade Ideas - Newser
Tech Rally: Is Forte Biosciences Inc trading at a discount2026 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn
Published on: 2026-04-05 11:22:35 - baoquankhu1.vn
Precision Trading with Forte Biosciences Inc. (FBRX) Risk Zones - Stock Traders Daily
Forte Biosciences and Pasithea Therapeutics Face Off in Financial Comparison - National Today
Forte Biosciences (NASDAQ: FBRX) CFO exercises RSUs, 134 shares withheld - Stock Titan
Forte Biosciences (FBRX) director boosts stake after RSU vesting - Stock Titan
Guggenheim reiterates Forte Biosciences stock rating ahead of data By Investing.com - Investing.com India
Forte Biosciences Inc (FBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):